SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Beyond Air, Inc. – ‘10-K’ for 12/31/17 – ‘R1’

On:  Friday, 3/30/18, at 9:20am ET   ·   For:  12/31/17   ·   Accession #:  1178913-18-1051   ·   File #:  0-55759

Previous ‘10-K’:  ‘10-K’ on 3/31/17 for 12/31/16   ·   Next:  ‘10-K’ on 6/28/19 for 3/31/19   ·   Latest:  ‘10-K’ on 6/22/23 for 3/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/18  Beyond Air, Inc.                  10-K       12/31/17   74:5.5M                                   Z-K Global Ltd/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    995K 
 2: EX-23.1     Consent of Experts or Counsel -- exhibit_23-1       HTML     22K 
 3: EX-31.1     Certification -- §302 - SOA'02 -- exhibit_31-1      HTML     31K 
 4: EX-31.2     Certification -- §302 - SOA'02 -- exhibit_31-2      HTML     30K 
 5: EX-32.1     Certification -- §906 - SOA'02 -- exhibit_32-1      HTML     24K 
 6: EX-32.2     Certification -- §906 - SOA'02 -- exhibit_32-2      HTML     23K 
13: R1          Document and Entity Information                     HTML     49K 
14: R2          Consolidated Balance Sheets                         HTML    108K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     40K 
16: R4          Consolidated Statements of Comprehensive Loss       HTML     51K 
17: R5          Statements of Changes in Consolidated               HTML     97K 
                Stockholders' Equity Deficiency                                  
18: R6          Statements of Consolidated Cash Flows               HTML    119K 
19: R7          General                                             HTML     39K 
20: R8          Significant Accounting Policies                     HTML     68K 
21: R9          Other Accounts Receivable                           HTML     34K 
22: R10         Property and Equipment, Net                         HTML     40K 
23: R11         Other Accounts Payable                              HTML     33K 
24: R12         Bank Loan                                           HTML     25K 
25: R13         Convertible Notes                                   HTML     41K 
26: R14         Fair Value Measurement                              HTML     53K 
27: R15         Taxes on Income                                     HTML     65K 
28: R16         Contingent Liabilities and Commitments              HTML     27K 
29: R17         Stockholders' Deficiency                            HTML    101K 
30: R18         Related Party Balances and Transactions             HTML     51K 
31: R19         Financial Expense, Net                              HTML     40K 
32: R20         Basic and Diluted Net Loss Per Share                HTML     37K 
33: R21         Subsequent Events                                   HTML     29K 
34: R22         Significant Accounting Policies (Policies)          HTML    123K 
35: R23         Significant Accounting Policies (Tables)            HTML     32K 
36: R24         Other Accounts Receivable (Tables)                  HTML     31K 
37: R25         Property and Equipment, Net (Tables)                HTML     39K 
38: R26         Other Accounts Payable (Tables)                     HTML     32K 
39: R27         Convertible Notes (Tables)                          HTML     36K 
40: R28         Fair Value Measurement (Tables)                     HTML     48K 
41: R29         Taxes on Income (Tables)                            HTML     57K 
42: R30         Stockholders' Deficiency (Tables)                   HTML     76K 
43: R31         Related Party Balances and Transactions (Tables)    HTML     50K 
44: R32         Financial Expense, Net (Tables)                     HTML     38K 
45: R33         Basic and Diluted Net Loss Per Share (Tables)       HTML     36K 
46: R34         General (Narrative) (Details)                       HTML     55K 
47: R35         Significant Accounting Policies (Schedule of        HTML     30K 
                Estimated useful lives)) (Details)                               
48: R36         Significant Accounting Policies (Fair Value of      HTML     39K 
                Options) (Details)                                               
49: R37         Other Accounts Receivable (Schedule of Other        HTML     28K 
                Accounts Receivable) (Details)                                   
50: R38         Property and Equipment, Net (Schedule of Property   HTML     38K 
                and Equipment) (Details)                                         
51: R39         Other Accounts Payable (Schedule of Other Accounts  HTML     32K 
                Payable) (Details)                                               
52: R40         Bank Loan (Details)                                 HTML     29K 
53: R41         Convertible Notes (Narrative) (Details)             HTML     38K 
54: R42         Convertible Notes (Schedule of Convertible Notes)   HTML     41K 
                (Details)                                                        
55: R43         Fair Value Measurement (Schedule of assumptions to  HTML     41K 
                estimate the Investors' and placement agent's                    
                warrants) (Details)                                              
56: R44         Fair Value Measurement (Schedule of components of   HTML     42K 
                the liability associated with such warrants)                     
                (Details)                                                        
57: R45         Taxes on Income (Narrative) (Details)               HTML     33K 
58: R46         Taxes on Income (Schedule of Deferred Tax Assets)   HTML     37K 
                (Details)                                                        
59: R47         Taxes on Income (Schedule of Income Loss Before     HTML     30K 
                Taxes) (Details)                                                 
60: R48         Taxes on Income (Schedule of Reconciliation of      HTML     26K 
                Unrecognized Tax Benefits) (Details)                             
61: R49         Contingent Liabilities and Commitments (Other)      HTML     27K 
                (Details)                                                        
62: R50         Contingent Liabilities and Commitments (Option      HTML     33K 
                Agreement) (Details)                                             
63: R51         Stockholders' Deficiency (Narrative) (Details)      HTML    191K 
64: R52         Stockholders' Deficiency (Summary of Option         HTML     58K 
                Activity For Employees And Directors) (Details)                  
65: R53         Stockholders' Deficiency (Summary of Options        HTML     44K 
                Granted to Non-Employees) (Details)                              
66: R54         Stockholders' Deficiency (Schedule of Share Based   HTML     33K 
                Compensation Expense) (Details)                                  
67: R55         Related Party Balances and Transactions             HTML     47K 
                (Narrative) (Details)                                            
68: R56         Related Party Balances and Transactions (Schedule   HTML     43K 
                of Related Party Transactions) (Details)                         
69: R57         Financial Expense, Net (Details)                    HTML     40K 
70: R58         Basic and Diluted Net Loss Per Share (Details)      HTML     34K 
71: R59         Subsequent Events (Details)                         HTML     48K 
73: XML         IDEA XML File -- Filing Summary                      XML    133K 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX     75K 
 7: EX-101.INS  XBRL Instance -- aitb-20171231                       XML   1.34M 
 9: EX-101.CAL  XBRL Calculations -- aitb-20171231_cal               XML    173K 
10: EX-101.DEF  XBRL Definitions -- aitb-20171231_def                XML    458K 
11: EX-101.LAB  XBRL Labels -- aitb-20171231_lab                     XML    943K 
12: EX-101.PRE  XBRL Presentations -- aitb-20171231_pre              XML    723K 
 8: EX-101.SCH  XBRL Schema -- aitb-20171231                         XSD    141K 
74: ZIP         XBRL Zipped Folder -- 0001178913-18-001051-xbrl      Zip    131K 


‘R1’   —   Document and Entity Information


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.8.0.1
Document and Entity Information - USD ($)
12 Months Ended
Document And Entity Information      
Entity Registrant Name AIT THERAPEUTICS, INC.    
Entity Central Index Key 0001641631    
Document Type 10-K    
Document Period End Date Dec. 31, 2017    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Is Entity a Well-known Seasoned Issuer? No    
Is Entity a Voluntary Filer? No    
Is Entity's Reporting Status Current? Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   8,397,056  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2017    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/30/18
3/29/18S-1/A
For Period end:12/31/1710-KT
6/30/1710-Q
 List all Filings 
Top
Filing Submission 0001178913-18-001051   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 7:39:36.2am ET